Department Of Neurooncology
Investigator
Andrew Lassman, MD
Phone
212-342-0571
Email
abl7@cumc.columbia.edu
Andrew B. Lassman, MD, is a Professor of Neurology and Associate Dean of Clinical Trials at the Columbia University Vagelos College of Physicians and Surgeons. Dr. Lassman also serves as Chief of the Department of Neurology Division of Neuro-Oncology and Associate Director for Clinical Trials at the Herbert Irving Comprehensive Cancer Center. As a clinician-scientist, Dr. Lassman focuses both his research and clinical efforts on improving the understanding and treatment of brain tumors.

Dr. Lassman has particular expertise in translational clinical trials for brain tumors, with molecular correlative analyses to understand the reasons for treatment success or failure, and to refine treatment paradigms. Dr. Lassman has led retrospective studies, single-institution prospective clinical trials, and multicenter prospective trials conducted nationally through the National Cancer Institute-sponsored National Clinical Trials Network. His contributions to the field of Neuro-Oncology have been recognized with numerous awards, including the Preuss Award in Neuro-Oncology from the American Academy of Neurology, the Boyer Clinical Research Award from Memorial Sloan-Kettering Cancer Center, and the Gary Lichtenstein Humanitarian Award from Voices Against Brain Cancer.

Dr. Lassman earned his BS and MS degrees in Molecular Biophysics and Biochemistry, as part of a combined four-year program at Yale University. He attained his MD from Columbia University College of Physicians and Surgeons and completed Neurology residency at the Neurological Institute of New York, at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Lassman completed his fellowship in Neuro-Oncology at Memorial Sloan-Kettering Cancer Center, where he joined the faculty and served as fellowship director, until his return to NewYork-Presbyterian/Columbia University Irving Medical Center.

Clinical Studies Managed By This Investigator:
Condition Study Title
Brain Tumors [ CLOSED ] A study for patients with newly-diagnosed Glioblastoma Multiforme using study drug Bortezomib
Breast Cancer [ CLOSED ] A study for patients with HER2 positive breast cancer using study drug Trastuzumab for treatment
Brain Tumors [ CLOSED ] A study for patients with glioblastoma using study drug ABT-414
Brain Tumors [ CLOSED ] Study for Patients with Anaplastic Astrocytoma That Progress/Recur After Radiation and Chemotherapy (Brain Tumors)
Brain Tumors [ CLOSED ] A study for patients with malignant glioblastoma or glioma using study drug PF-06840003
Brain Tumors [ CLOSED ] A study for patients with Glioblastoma using study drug Tesevatinib monotherapy
Brain Tumors [ CLOSED ] Study of the efficacy and safety of Selinexor (KPT-330) in patients with recurrent gliomas
Brain Tumors [ CLOSED ] Study of Radiotherapy with Adjuvant Drug versus Radiotherapy with PCV Chemotherapy in Patients with Glioma
Brain Tumors [ CLOSED ] Study of Treatment Effects in Subjects with Glioblastoma Multiforme (GBM) - Glioma, Brain Tumor
Brain Tumors Study of Vaccine for Cytomegalovirus (CMV) in Patients with Brain Tumors
Brain Tumors [ CLOSED ] Study of Drug BGB-290 in Patients with Glioblastoma
Brain Tumors [ CLOSED ] Study for Management of Eye Side Effects in Patients with EGFR-Amplified Glioblastoma Receiving ABT-414
Brain Tumors [ CLOSED ] REGAL- Recurrent Glioblastoma Treated with Selinexor and Temozolomide
Cancer [ CLOSED ] Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
Brain Tumors [ CLOSED ] Study of ONC201 in Adults With Recurrent H3 K27M-mutant Glioma
Brain Tumors [ CLOSED ] Study of ABBV-321 in Subjects with Advanced Solid Tumors Associated with Overexpression of Epidermal Growth Factor Receptor (EGFR)
Brain Tumors Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM
Brain Tumors [ CLOSED ] Study of AG-881 in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)
Brain Tumors [ CLOSED ] A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Brain Cancer [ CLOSED ] Study for Patients with Anaplastic Astrocytoma That Progress/Recur After Radiation and Chemotherapy
Brain Cancer [ CLOSED ] Study of ONC201 in Adults With Recurrent H3 K27M-mutant Glioma
Brain Cancer Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM
Brain Cancer [ CLOSED ] Study of AG-881 in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)
Brain Cancer [ CLOSED ] A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Brain Cancer Study of Vaccine for Cytomegalovirus (CMV) in Patients with Brain Tumors
Brain Cancer [ CLOSED ] Study of Pemigatinib in Patients with Glioblastoma (GBM) or Other CNS Tumors
Brain Tumors [ CLOSED ] Study of Pemigatinib in Patients with Glioblastoma (GBM) or Other CNS Tumors